Discount sale is live
all report title image

BIOTECH INGREDIENTS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025-2032)

Biotech Ingredients Market, By Product Type (Monoclonal Antibodies, Vaccines, Active Pharmaceutical Ingredients (Biotech-derived APIs), Specialty Proteins, Hormones and Growth Factors, Therapeutic Enzymes, Blood Factors (Recombinant), Nucleotides and Oligonucleotides, Biotech-Derived Polysaccharides, Amino Acids (Pharma Grade), and Others (Cytokines, etc.)), By Source (Microbial Fermentation, Cell Culture Based Sources, Recombinant DNA Technology, and Synthetic Biology Derived Molecules), By Expression System (Mammalian Expression Systems, Microbial Expression Systems, Yeast Expression Systems, Plant Expression Systems, and Insect Expression Systems), By End User (Biopharmaceutical Companies, Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs/CDMOs), Diagnostic Laboratories, and Academic and Research Institutes, By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

  • Published In : 05 Sep, 2025
  • Code : CMI8543
  • Pages :140
  • Formats :
      Excel and PDF
  • Industry : Healthcare IT
  • 歴史的範囲: 2020 - 2024
  • 歴史的範囲: 2020 - 2024
Ingographics Image

The global biotech ingredients market is estimated to be valued at USD 55.21 Bn in 2025 and is expected to reach USD 94.01 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 7.9% from 2025 to 2032. The global biotech ingredients market represents a dynamic and rapidly evolving sector that sits at the intersection of biotechnology innovation and ingredient manufacturing across multiple industries. Biotech ingredients encompass a diverse range of products derived from living organisms or produced through biotechnological processes, including enzymes, amino acids, organic acids, vitamins, antibiotics, and specialty chemicals used in pharmaceuticals, food and beverages, cosmetics, agriculture, and industrial applications.

These ingredients are manufactured using advanced fermentation technologies, genetic engineering, and bioprocessing techniques that leverage microorganisms, plant cells, or animal cells as production platforms. The market has witnessed unprecedented growth driven by increasing consumer preference for natural and sustainable products, stringent regulatory frameworks favoring bio-based alternatives over synthetic chemicals, and technological advancements in biotechnology that have enhanced production efficiency and cost-effectiveness. The sector benefits from growing applications in functional foods, nutraceuticals, personalized medicine, and green chemistry initiatives, while pharmaceutical companies increasingly rely on biotech ingredients for drug development and manufacturing.

Market Dynamics

The global biotech ingredients market is propelled by several key drivers that create substantial growth momentum across multiple industry verticals. The primary growth driver stems from escalating consumer awareness regarding health and wellness, leading to increased demand for natural and organic products in food, beverages, and personal care applications, which directly translates to higher adoption of biotech-derived ingredients. Pharmaceutical industry expansion, particularly in biologics and biosimilars, significantly drives market growth as biotech ingredients serve as critical raw materials for drug manufacturing and development processes. Technological advancements in fermentation processes, genetic engineering, and synthetic biology have dramatically improved production efficiency, reduced manufacturing costs, and enabled the development of novel biotech ingredients with enhanced functionalities.

However, the market faces notable restraints including high initial capital investments required for biotechnology infrastructure development, complex regulatory approval processes that can delay product commercialization, and technical challenges associated with scaling up production from laboratory to industrial levels. Additionally, competition from established synthetic alternatives and concerns about intellectual property protection in biotechnology can limit market penetration. Despite these challenges, significant opportunities emerge from the growing emphasis on sustainability and circular economy principles, which favor bio-based ingredients over petroleum-derived chemicals. The expanding applications in emerging sectors such as personalized nutrition, precision medicine, and bio-based materials present lucrative growth avenues. Furthermore, increasing government support through favorable policies, research grants, and tax incentives for biotechnology development creates an enabling environment for market expansion, while strategic partnerships between biotechnology companies and end-user industries facilitate innovation and market penetration across diverse application segments.

Key Features of the Study

  • This report provides in-depth analysis of the global biotech ingredients market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global biotech ingredients market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Lonza, WuXi Biologics, Samsung Biologics, FUJIFILM Diosynth Biotechnologies, Boehringer Ingelheim BioXcellence, Catalent Biologics, Thermo Fisher Scientific Patheon, AGC Biologics, Rentschler Biopharma, AbbVie Contract Manufacturing, Ajinomoto Bio-Pharma Services, Bachem, CordenPharma, Evonik Health Care, and Kyowa Hakko Bio.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global biotech ingredients market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biotech ingredients market.

Market Segmentation

  • Product Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Monoclonal Antibodies
    • Vaccines
    • Active Pharmaceutical Ingredients (Biotech-derived APIs)
    • Specialty Proteins
    • Hormones and Growth Factors
    • Therapeutic Enzymes
    • Blood Factors (Recombinant)
    • Nucleotides and Oligonucleotides
    • Biotech-Derived Polysaccharides
    • Amino Acids (Pharma Grade)
    • Others (Cytokines, etc.)
  • Source Insights (Revenue, USD Bn, 2020 - 2032)
    • Microbial Fermentation
    • Cell Culture Based Sources
    • Recombinant DNA Technology
    • Synthetic Biology Derived Molecules
  • Expression System Insights (Revenue, USD Bn, 2020 - 2032)
    • Mammalian Expression Systems
    • Microbial Expression Systems
    • Yeast Expression Systems
    • Plant Expression Systems
    • Insect Expression Systems
  • End User Insights (Revenue, USD Bn, 2020 - 2032)
    • Biopharmaceutical Companies
    • Contract Research Organizations (CROs)
    • Contract Manufacturing Organizations (CMOs/CDMOs)
    • Diagnostic Laboratories
    • Academic and Research Institutes
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • GCC Countries
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • North Africa
      • Central Africa
  • Key Players Insights
    • Lonza
    • WuXi Biologics
    • Samsung Biologics
    • FUJIFILM Diosynth Biotechnologies
    • Boehringer Ingelheim BioXcellence
    • Catalent Biologics
    • Thermo Fisher Scientific Patheon
    • AGC Biologics
    • Rentschler Biopharma
    • AbbVie Contract Manufacturing
    • Ajinomoto Bio-Pharma Services
    • Bachem
    • CordenPharma
    • Evonik Health Care
    • Kyowa Hakko Bio

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
    • Global Biotech Ingredients Market, By Product Type
    • Global Biotech Ingredients Market, By Source
    • Global Biotech Ingredients Market, By Expression System
    • Global Biotech Ingredients Market, By End User
    • Global Biotech Ingredients Market, By Region
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Driver
      • Restraint
      • Opportunity
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
    • Industry Trends
  4. Global Biotech Ingredients Market, By Product Type, 2020-2032, (USD Bn)
    • Introduction
      • Market Share Analysis, 2025 and 2032 (%)
      • Y-o-Y Growth Analysis, 2021 - 2032
      • Segment Trends
    • Monoclonal Antibodies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Active Pharmaceutical Ingredients (Biotech-derived APIs)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Specialty Proteins
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Hormones and Growth Factors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Therapeutic Enzymes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Blood Factors (Recombinant)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Nucleotides and Oligonucleotides
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Biotech-Derived Polysaccharides
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Amino Acids (Pharma Grade)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Others (Cytokines, etc.)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  5. Global Biotech Ingredients Market, By Source, 2020-2032, (USD Bn)
    • Introduction
      • Market Share Analysis, 2025 and 2032 (%)
      • Y-o-Y Growth Analysis, 2021 - 2032
      • Segment Trends
    • Microbial Fermentation
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Cell Culture Based Sources
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Recombinant DNA Technology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Synthetic Biology Derived Molecules
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  6. Global Biotech Ingredients Market, By Expression System, 2020-2032, (USD Bn)
    • Introduction
      • Market Share Analysis, 2025 and 2032 (%)
      • Y-o-Y Growth Analysis, 2021 - 2032
      • Segment Trends
    • Mammalian Expression Systems
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Microbial Expression Systems
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Yeast Expression Systems
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Plant Expression Systems
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Insect Expression Systems
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  7. Global Biotech Ingredients Market, By End User, 2020-2032, (USD Bn)
    • Introduction
      • Market Share Analysis, 2025 and 2032 (%)
      • Y-o-Y Growth Analysis, 2021 - 2032
      • Segment Trends
    • Biopharmaceutical Companies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Contract Research Organizations (CROs)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Contract Manufacturing Organizations (CMOs/CDMOs)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Diagnostic Laboratories
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Academic and Research Institutes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  8. Global Biotech Ingredients Market, By Region, 2020 - 2032, Value (USD Bn)
    • Introduction
      • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
      • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
      • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
      • Market Size and Forecast, By Expression System, 2020 - 2032, Value (USD Bn)
      • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
      • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
      • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
      • Market Size and Forecast, By Expression System, 2020 - 2032, Value (USD Bn)
      • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
      • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
      • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
      • Market Size and Forecast, By Expression System, 2020 - 2032, Value (USD Bn)
      • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
      • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
      • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
      • Market Size and Forecast, By Expression System, 2020 - 2032, Value (USD Bn)
      • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
      • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
      • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
      • Market Size and Forecast, By Expression System, 2020 - 2032, Value (USD Bn)
      • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
      • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
      • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
      • Market Size and Forecast, By Expression System, 2020 - 2032, Value (USD Bn)
      • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
      • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
        • South Africa
        • North Africa
        • Central Africa
  9. Competitive Landscape
    • Lonza
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • WuXi Biologics
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Samsung Biologics
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • FUJIFILM Diosynth Biotechnologies
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Boehringer Ingelheim BioXcellence
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Catalent Biologics
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Thermo Fisher Scientific Patheon
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • AGC Biologics
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Rentschler Biopharma
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • AbbVie Contract Manufacturing
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Ajinomoto Bio-Pharma Services
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Bachem
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • CordenPharma
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Evonik Health Care
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Kyowa Hakko Bio
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
  10. Analyst Recommendations
    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  11. References and Research Methodology
    • References
    • Research Methodology
    • About Us

*Browse 32 market data tables and 28 figures on ‘Biotech Ingredients Market' - Global forecast to 2032

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2025 Coherent Market Insights Pvt Ltd. All Rights Reserved.